Related Experiment Video
Updated: Aug 29, 2026

Co-Culture In Vitro Systems to Reproduce the Cancer-Immunity Cycle
Published on: June 7, 2024
Chemical carcinogens as foreign bodies and some pitfalls regarding cancer immune surveillance
Thomas Blankenstein1, Zhihai Qin
1Max-Delbrück-Centrum for Molecular Medicine, 13092 Berlin, Germany.
Abstract:
Interferon-gamma-receptor (IFN-gammaR)-deficient mice are more susceptible to tumor induction by methylcholanthrene (MCA) in comparison to control littermates. The cellular source of IFNgamma is not known, but the absence of T cells does not significantly increase the incidence of MCA-induced tumors. However, it appears that the presence of T cells in combination with unknown, perhaps environmental, factors can decrease MCA-induced tumor incidence, indicating that IFN-gamma of unknown origin contributes to the protective response. The current knowledge of cancer biology, immune regulation, and tumor-promoting effects of inflammation are difficult to reconcile with the concept of immune surveillance against non-virus-associated cancer. Analysis of the primary MCA-treated mouse indicates, as one protective mechanism, a tissue repair response against MCA-induced damage, in the course of which MCA is encapsulated and persists for long time in tumor-free mice, termed foreign-body reaction. The protection from DNA damage could simultaneously diminish tissue injury and malignant transformation. We argue that inhibition of MCA-induced carcinogenesis is mechanistically different from tumor transplantation immunity and that a longer latency in MCA-treated mice is unlikely due to T cell-mediated tumor recognition and selection of less immunogenic variants. We discuss that the IFNgammaR-dependent mechanism against MCA is unrelated to the original concept of T cell-mediated immune surveillance and that the increased spontaneous tumor incidence observed in some immune-deficient mice is likely to be explained by opportunistic infection and tumor-promoting chronic inflammation.
Insights
Interferon-gamma-receptor (IFN-gammaR) deficiency increases susceptibility to methylcholanthrene (MCA)-induced tumors. A foreign-body reaction, not T-cell surveillance, appears to protect against MCA carcinogenesis.
Area of Science:
- Immunology
- Cancer Biology
- Carcinogenesis
Background:
- Interferon-gamma-receptor (IFN-gammaR) deficient mice show increased susceptibility to methylcholanthrene (MCA) induced tumors.
- The role of T cells and the source of IFN-gamma in MCA carcinogenesis remain unclear.
- Existing knowledge of cancer, immune regulation, and inflammation challenges traditional immune surveillance concepts for non-viral cancers.
Purpose of the Study:
- To investigate the role of IFN-gammaR in methylcholanthrene (MCA)-induced tumor development.
- To explore alternative protective mechanisms against chemical carcinogenesis beyond T-cell mediated immune surveillance.
- To reconcile the observed phenomena with current understanding of cancer biology and inflammation.
Main Methods:
- Comparative analysis of tumor incidence in IFN-gammaR-deficient mice versus control littermates following MCA exposure.
- Assessment of the impact of T-cell absence on MCA-induced tumor incidence.
- Histopathological analysis of MCA-treated tissues to identify protective mechanisms, such as foreign-body reactions.
Main Results:
- IFN-gammaR-deficient mice exhibit higher susceptibility to MCA-induced tumors.
- Absence of T cells did not significantly alter MCA-induced tumor incidence, suggesting T-cell independent protection.
- A foreign-body reaction, involving encapsulation of MCA, was identified as a protective mechanism against carcinogenesis in tumor-free mice.
- This tissue repair response may prevent DNA damage, tissue injury, and malignant transformation.
Conclusions:
- IFN-gammaR-dependent protection against MCA carcinogenesis is distinct from T-cell mediated tumor transplantation immunity.
- The observed protection is likely mediated by a tissue repair response (foreign-body reaction) rather than classical immune surveillance.
- Increased tumor incidence in some immune-deficient mice may stem from opportunistic infections and chronic inflammation, not a lack of tumor recognition.
More Related Videos
Related Concept Videos
Cancer Prevention
Some...
Mutagenicity and Carcinogenicity
Tumor Immunotherapy
Skin Cancer
Basal Cell Carcinoma (BCC): BCC is the most common type of skin cancer, accounting for about 80% of cases. It typically develops in...
Antigens Involved in Adaptive Immunity
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Immune Surveillance by NK Cells and Phagocytes
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
![Chemical-Induced Skin Carcinogenesis Model Using Dimethylbenz[a]Anthracene and 12-O-Tetradecanoyl Phorbol-13-Acetate (DMBA-TPA)](/_next/image?url=https%3A%2F%2Fcloudfront.jove.com%2FCDNSource%2Fteasers%2F60445.jpg&w=3840&q=50)
